# Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers

> **NCT01181440** · PHASE3 · COMPLETED · sponsor: **Organogenesis** · enrollment: 281 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** Dermagraft(R)
- **OTHER:** Conventional care

## Key facts

- **NCT ID:** NCT01181440
- **Lead sponsor:** Organogenesis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-09
- **Primary completion:** 1997-01
- **Final completion:** 1997-01
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181440, "Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*